$FTII
Futuretech II Acquisition Corp Stock $ftii

$ftii Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224032073 Filed on August 14, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$284.9K	$310.9K	$171.9K
YoY Change	-16.21%	40.61%	-7.44%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$284.9K	$310.9K	$171.9K
YoY Change	-16.32%	40.61%	-7.44%
Operating Profit
YoY Change
Interest Expense	$283.1K	$100.0K	$819.7K
YoY Change	-80.74%	0.0%	-18.16%
% of Operating Profit
Other Income/Expense, Net	$283.1K	$536.3K
YoY Change	-80.72%	-58.37%
Pretax Income	-$1.810K	$225.4K	$792.3K
YoY Change	-100.16%	-78.88%	-2.89%
Income Tax	$42.65K	$95.83K	$185.7K
% Of Pretax Income		42.51%	23.43%
Net Earnings	-$44.46K	$129.6K	$606.6K
YoY Change	-105.32%	-83.95%	19.97%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.01	$0.02	$0.06
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$480.00	$410.00	$17.58K
YoY Change	-99.9%	-99.73%	-93.31%
Cash & Equivalents	$476.00	$413.00	$17.58K
Short-Term Investments
Other Short-Term Assets	$63.00K	$22.50K	$64.04K
YoY Change	-85.69%	-91.78%	-59.37%
Inventory
Prepaid Expenses	$63.00K	$22.50K	$64.04K
Receivables
Other Receivables
Total Short-Term Assets	$795.4K	$754.8K	$938.5K
YoY Change	15.67%	78.07%	123.26%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$26.66M	$26.23M	$61.84M
YoY Change	-78.41%	-78.4%	-48.02%
Other Assets
YoY Change
Total Long-Term Assets	$26.66M	$26.23M	$61.84M
YoY Change	-78.42%	-78.4%	-48.06%
TOTAL ASSETS
Total Short-Term Assets	$795.4K	$754.8K	$938.5K
Total Long-Term Assets	$26.66M	$26.23M	$61.84M
Total Assets	$27.46M	$26.98M	$62.78M
YoY Change	-77.9%	-77.85%	-47.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$414.8K	$448.7K	$295.1K
YoY Change	38.25%	97.48%	126.63%
Accrued Expenses	$1.202M	$1.152M	$739.5K
YoY Change		355.97%	264.79%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.627M	$2.568M	$2.122M
YoY Change	-32.35%	9.53%	169.44%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.450M	$3.450M	$3.450M
YoY Change	-1.43%	0.0%	0.0%
Total Long-Term Liabilities	$3.450M	$3.450M	$3.450M
YoY Change	-1.43%	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.627M	$2.568M	$2.122M
Total Long-Term Liabilities	$3.450M	$3.450M	$3.450M
Total Liabilities	$6.077M	$6.018M	$5.572M
YoY Change	-17.13%	3.86%	31.49%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.828M	-$3.902M	-$3.327M
YoY Change	-20.94%	-14.25%	3.01%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.827M	-$3.902M	$57.21M
YoY Change
Total Liabilities & Shareholders Equity	$27.46M	$26.98M	$62.78M
YoY Change	-77.9%	-77.85%	-47.46%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	-$44.46K	$129.6K	$606.6K
YoY Change	-105.32%	-83.95%	19.97%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$309.3K	-$282.1K	-$799.8K
YoY Change	-51.67%	150.74%	1116.47%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$150.0K	$36.27M	-$375.0K
YoY Change	-76.56%	-3254.19%
Cash From Investing Activities	-$150.0K	$36.27M	-$375.0K
YoY Change	-76.56%	-3254.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	459.4K	-$36.01M	1.187M
YoY Change	-61.07%	-3231.16%
NET CHANGE
Cash From Operating Activities	-309.3K	-$282.1K	-799.8K
Cash From Investing Activities	-150.0K	$36.27M	-375.0K
Cash From Financing Activities	459.4K	-$36.01M	1.187M
Net Change In Cash	60.00	-$17.17K	12.08K
YoY Change	-100.06%	-84.74%	-118.37%
FREE CASH FLOW
Cash From Operating Activities	-$309.3K	-$282.1K	-$799.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	283084	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	283084	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1468385	usd
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41289
	dei	Entity Registrant Name EntityRegistrantName	FUTURETECH II ACQUISITION CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-2551539
	dei	Entity Address Address Line1 EntityAddressAddressLine1	128 Gail Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	New Rochelle
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10805
	dei	City Area Code CityAreaCode	(914)
	dei	Local Phone Number LocalPhoneNumber	316-4805
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001889450
CY2024Q2	FTII	Extension Fee Receivable ExtensionFeeReceivable		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets		usd
	FTII	Cash In Transit To Trust CashInTransitToTrust		usd
	FTII	Capital Contribution From Sponsor CapitalContributionFromSponsor		usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	FTII	Excise Tax On Class Common Stock Redemptions ExciseTaxOnClassCommonStockRedemptions		usd
	dei	Document Type DocumentType	10-Q
CY2024Q2	us-gaap	Cash Cash	476	usd
CY2023Q4	us-gaap	Cash Cash	17578	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	63000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	64043	usd
CY2023Q4	FTII	Extension Fee Receivable ExtensionFeeReceivable	125000	usd
CY2024Q2	us-gaap	Other Receivables OtherReceivables	731912	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	731912	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	795388	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	938533	usd
CY2024Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	26660351	usd
CY2023Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	61839164	usd
CY2024Q2	us-gaap	Assets Assets	27455739	usd
CY2023Q4	us-gaap	Assets Assets	62777697	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	414761	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	295138	usd
CY2024Q2	FTII	Excise Tax Payable ExciseTaxPayable	1005209	usd
CY2023Q4	FTII	Excise Tax Payable ExciseTaxPayable	642389	usd
CY2024Q2	FTII	Franchise Tax Payable Current FranchiseTaxPayableCurrent	194364	usd
CY2023Q4	FTII	Franchise Tax Payable Current FranchiseTaxPayableCurrent	94364	usd
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	1009833	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1087603	usd
CY2024Q2	FTII	Accrued Offering Costs Current AccruedOfferingCostsCurrent	2708	usd
CY2023Q4	FTII	Accrued Offering Costs Current AccruedOfferingCostsCurrent	2708	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2626875	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2122202	usd
CY2024Q2	FTII	Deferred Underwriting Commission DeferredUnderwritingCommission	3450000	usd
CY2023Q4	FTII	Deferred Underwriting Commission DeferredUnderwritingCommission	3450000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	6076875	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5572202	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3827643	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3327054	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-3827291	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-3326702	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27455739	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	62777697	usd
CY2024Q2	FTII	Franchise Tax FranchiseTax	50000	usd
CY2023Q2	FTII	Franchise Tax FranchiseTax	50000	usd
	FTII	Franchise Tax FranchiseTax	100000	usd
	FTII	Franchise Tax FranchiseTax	100000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	204894	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	260441	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	435828	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	401566	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	284894	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	340441	usd
	us-gaap	Operating Expenses OperatingExpenses	595828	usd
	us-gaap	Operating Expenses OperatingExpenses	561566	usd
CY2023Q2	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	1468385	usd
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	819427	usd
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	2756883	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	819427	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2756883	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1810	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1127944	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	223599	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2195317	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	42647	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	291561	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	138480	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	551645	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-44457	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	836383	usd
	us-gaap	Net Income Loss NetIncomeLoss	85119	usd
	us-gaap	Net Income Loss NetIncomeLoss	1643672	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3229352	usd
CY2023Q1	FTII	Adjustment To Additional Paid In Capital Remeasurement Adjustment AdjustmentToAdditionalPaidInCapitalRemeasurementAdjustment	-2128414	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	807289	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-4550477	usd
CY2023Q2	FTII	Adjustment To Additional Paid In Capital Remeasurement Adjustment AdjustmentToAdditionalPaidInCapitalRemeasurementAdjustment	-1126824	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	836383	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-4840918	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-3326702	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-362820	usd
CY2024Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	615511	usd
CY2024Q1	FTII	Stock Issued During Period Value Capital Contribution StockIssuedDuringPeriodValueCapitalContribution	273667	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	129577	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-3901789	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-3901789	usd
CY2024Q2	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	340436	usd
CY2024Q2	FTII	Stock Issued During Period Value Capital Contribution StockIssuedDuringPeriodValueCapitalContribution	459391	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-44457	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-3827291	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-3827291	usd
	us-gaap	Net Income Loss NetIncomeLoss	85119	usd
	us-gaap	Net Income Loss NetIncomeLoss	1643672	usd
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	819427	usd
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	2756883	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1043	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	41153	usd
	FTII	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	100000	usd
	FTII	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	-200000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-77770	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	349645	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-77654	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	119625	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	174066	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-591410	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-752999	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	500000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2300000	usd
	FTII	Cash In Transit To Trust CashInTransitToTrust	125000	usd
	FTII	Proceeds From Cash Withdrawn From Trust ProceedsFromCashWithdrawnFromTrust	36498240	usd
	FTII	Proceeds From Cash Withdrawn From Trust ProceedsFromCashWithdrawnFromTrust	507636	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	36123240	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1792364	usd
	FTII	Capital Contribution From Sponsor CapitalContributionFromSponsor	-733058	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	36281990	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	440100	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	2771485	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-35548932	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2331385	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-17102	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-213978	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17578	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	262756	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	476	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	48778	usd
	FTII	Remeasurement Adjustment RemeasurementAdjustment	955947	usd
	FTII	Remeasurement Adjustment RemeasurementAdjustment	3255238	usd
	FTII	Excise Tax On Class Common Stock Redemptions ExciseTaxOnClassCommonStockRedemptions	362820	usd
CY2022Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	117300000	usd
CY2022Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.00
CY2024Q2	us-gaap	Cash Cash	476	usd
CY2024Q2	FTII	Working Capital Deficit WorkingCapitalDeficit	1831487	usd
CY2023Q4	us-gaap	Cash Cash	17578	usd
CY2023Q4	FTII	Working Capital Deficit WorkingCapitalDeficit	1183669	usd
CY2024Q2	FTII	Percentage Of Assets Held In Trust Entering Into Business Combination Agreement PercentageOfAssetsHeldInTrustEnteringIntoBusinessCombinationAgreement	0.80	pure
CY2024Q2	FTII	Percentage Of Post Transaction Ownership Required To Complete Business Combination PercentageOfPostTransactionOwnershipRequiredToCompleteBusinessCombination	0.50	pure
	us-gaap	Interest Expense InterestExpense	100000	usd
CY2024Q2	us-gaap	Cash Cash	476	usd
CY2024Q2	FTII	Working Capital Deficit WorkingCapitalDeficit	1831487	usd
CY2023Q4	us-gaap	Cash Cash	17578	usd
CY2023Q4	FTII	Working Capital Deficit WorkingCapitalDeficit	1183669	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zw1GZvPK3n05" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_z3FdWiAU7ZPc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of Credit Risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $<span id="xdx_908_eus-gaap--CashFDICInsuredAmount_iI_c20240630_zgy4sI5l8vO9" title="Cash FDIC insured amount">250,000</span>. At June 30, 2024 and December 31, 2023, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q2	us-gaap	Cash Cash	476	usd
CY2023Q4	us-gaap	Cash Cash	17578	usd
CY2024Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	117300000	usd
CY2022Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.00
CY2024Q2	us-gaap	Assets Held In Trust AssetsHeldInTrust	26660351	usd
CY2023Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	61839164	usd
CY2024Q2	us-gaap	Assets Held In Trust AssetsHeldInTrust	26660351	usd
CY2023Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	61839164	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022Q3	FTII	Percentage Of Exercise Tax To Be Imposed PercentageOfExerciseTaxToBeImposed	0.01	pure
CY2022Q3	FTII	Percentage Of Exercise Tax To Be Imposed PercentageOfExerciseTaxToBeImposed	0.01	pure
CY2024Q2	us-gaap	Other Receivables OtherReceivables	731912	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	731912	usd
	us-gaap	Sponsor Fees SponsorFees	10000	usd
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.20	pure

Files In Submission

Name	View Source	Status
0001493152-24-032073-index-headers.html	Edgar Link	pending
0001493152-24-032073-index.html	Edgar Link	pending
0001493152-24-032073.txt	Edgar Link	pending
0001493152-24-032073-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
ftii-20240630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
ftii-20240630_cal.xml	Edgar Link	unprocessable
ftii-20240630_def.xml	Edgar Link	unprocessable
ftii-20240630_lab.xml	Edgar Link	unprocessable
ftii-20240630_pre.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FTII
Futuretech II Acquisition Corp Stock $ftii

2024 Q2 Form 10-Q Financial Statement

#000149315224032073 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FTII Futuretech II Acquisition Corp Stock $ftii

2024 Q2 Form 10-Q Financial Statement

#000149315224032073 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FTII
Futuretech II Acquisition Corp Stock $ftii